Poseida Therapeutics, Inc.

Historical 13F Holders

Symbol
PSTX
CUSIP
73730P108
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 73730P108 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
FMR LLC 13G/A
0% 2/7/2025
Event 1/31/2025
Malin Life Sciences Holdings Ltd 13G/A
0% 1/15/2025
Event 1/8/2025
Nomura Holdings Inc 13G/A
0% 5/15/2025
Event 3/31/2025
Pentwater Capital Management LP 13D/A
0% 1/13/2025
Event 1/8/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 2 100 k $308 k
2024 Q4 125 54.1 M $519 M
2024 Q3 102 53.7 M $153 M
2024 Q2 101 53.6 M $156 M
2024 Q1 100 54.0 M $172 M
2023 Q4 96 46.2 M $155 M
2023 Q3 91 45.2 M $108 M
2023 Q2 98 44.5 M $78.4 M
2023 Q1 105 44.1 M $136 M
2022 Q4 95 43.2 M $228 M
2022 Q3 72 40.1 M $142 M
2022 Q2 57 22.5 M $58.1 M
2022 Q1 67 24.2 M $108 M
2021 Q4 68 26.2 M $179 M
2021 Q3 69 26.2 M $191 M
2021 Q2 75 28.7 M $287 M
2021 Q1 65 29.7 M $284 M
2020 Q4 57 26.3 M $288 M
2020 Q3 53 25.4 M $217 M